Bio Protocol vs Bulla — how do they compare? Bio Protocol trades at Rp516.9 (market cap Rp1,15T, Rp264,79M 24h volume), while Bulla trades at Rp113.39 (market cap Rp108,26M, Rp9,93M 24h volume). The key difference: Bio Protocol is far larger — about 10622.6× Bulla's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 1B / 1B BULLA (100%) for Bulla. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Bulla for 5 Days on average.
| BIO | BULLA | |
|---|---|---|
Market Cap | Rp1,15T | Rp108,26M |
Volume (24h) | Rp264,79M | Rp9,93M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 1B / 1B BULLA (100%) |
Typical Hold Time | 16 Days | 5 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
BULLA trades at Rp113.3941 with a market cap of Rp108.26M and 100% circulating supply. The token shows limited recent price movement and low trading volume, indicating thin liquidity. No major protocol updates or ecosystem developments were observed in recent data. The asset remains a micro-cap cryptocurrency with minimal on-chain activity and exchange presence.
Outlook: High risk due to low liquidity and market cap. Opportunities exist if the project gains traction, but investors should be cautious of extreme volatility and potential liquidity traps. Major risks include regulatory uncertainty and lack of developer activity.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Bulla is a decentralized protocol designed to facilitate on-chain credit management and automated payment streaming. It provides businesses with tools to handle invoicing, payroll, and loans in a transparent, trustless environment. BULLA is the native token used for platform fees, governance, and incentivizing network participation.
Read more on BULLA →